TICAGRELOR

TICAGRELOR

Biochem/physiol Actions

Ticagrelor is an antithrombotic antiplatelet drug that acts by direct and reversible competitive inhibition of the adensoine purinoceptor P2Y12 receptor. It has clinical benefits in people affected with acute coronary syndrome. It might also play a beneficial role on endothelial function. Ticagrelor can prevent the uptake of adenosine by human erythrocytes and can promote the liberation of adenosine triphosphate (ATP) from human erythrocytes.

General description

Ticagrelor (AZD6140) is a cyclopentyl-triazolopyrimidine.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour InChI key InChI Manufacturer Form Assay Price Quantity
3576374 TICAGRELOR white to beige OEKWJQXRCDYSHL-FNOIDJSQSA-N 1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34 SIGMA-ALDRICH powder ≥98% (HPLC)
£77.16 (exc VAT) per 10MG
-
+
3576375 TICAGRELOR white to beige OEKWJQXRCDYSHL-FNOIDJSQSA-N 1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34 SIGMA-ALDRICH powder ≥98% (HPLC)
£156.00 (exc VAT) per 50MG
-
+